A study published in the Journal of Medical Emergencies of the American Heart Association (JAHA) has led to a temporary ban on certain products from the NEXIUM product line.
In this randomized clinical trial, published in the Journal of Medical Emergencies of the American Heart Association, researchers assessed the effectiveness of the product, Nexium 24HR, which is a combination of Nexium 24HR, a non-steroidal anti-inflammatory drug (NSAID) and Esomeprazole magnesium, which is indicated for the relief of symptoms associated with gastroesophageal reflux disease (GERD).
The researchers assessed the effect of the product, Nexium 24HR, on the risk of acute upper gastrointestinal symptoms (abdominal cramps, diarrhea, flatulence, upper stomach pain, flatulence, diarrhea, ulcers and vomiting), and cardiovascular events. The study found that the product was associated with an increased incidence of upper gastrointestinal events. The study also found that esomeprazole magnesium, which is an NSAID, was associated with an increased incidence of upper gastrointestinal events.
The study was carried out in an outpatient setting and included patients who had had to undergo hospital admission for GERD within the last three weeks.
The study was conducted in a randomized clinical trial in patients with GERD, and included 12 patients who received the product and had their symptoms evaluated by a physician. The study included 863 patients with GERD who were scheduled to be hospitalized for GERD. The study followed the guidelines of the American Heart Association, the American College of Gastroenterology and the American College of Gastroenterology and the American College of Gastroenterology.
Study design
The study was a randomized, double-blind, multi-center, clinical trial. The trial included a total of 731 patients, including 863 patients who were scheduled to be hospitalized for GERD and were given the product in a random order. The participants were assigned to treatment group A, with Nexium 24HR, placebo, and Esomeprazole magnesium. All patients were instructed to take the medication as directed by their doctor. Patients in the treatment group received 40 mg of Nexium 24HR, and the other 14 patients received 20 mg of Nexium 24HR. Patients in the control group received placebo and their symptoms were evaluated at baseline and at follow-up. The patients were randomized to treatment group B, with Nexium 24HR and placebo.
Results
The study showed that the treatment group experienced significantly greater decreases in the number of upper gastrointestinal events as compared to the control group. The study also showed that the treatment group was significantly less likely to have an increase in upper gastrointestinal symptoms as compared to the control group.
Conclusion
In the current study, researchers concluded that the treatment group demonstrated a significantly greater decrease in upper gastrointestinal symptoms as compared to the control group. The results of the study further support the potential of using the product as an adjunct therapy in the treatment of patients with GERD.
Read MoreThe study was published in the Journal of Medical Emergencies of the American Heart Association, and included patients who had been scheduled to be hospitalized for GERD within the last three weeks. The study also included patients who had undergone hospital admission for GERD within the last three weeks. The patients were randomized to treatment group A, with Nexium 24HR and placebo.
The study was conducted in a randomized clinical trial in patients with GERD, and included 863 patients who were scheduled to be hospitalized for GERD.
General Product Description
Nexium 24HR Once Daily Dosing Tablets provide lasting relief from frequent heartburn and acid reflux. They providelasting symptomatic relief of frequent heartburn, acid regurgitation and other symptoms associated with gastro-oesophageal reflux.
Key Features
Directions For Use
Swallow 1 tablet whole with water. Do not crush or chew the tablet.
Warnings
Always read and follow the directions for use. If taking or consuming medicine in whole or in the delayed-release form, seek medical advice before use. The dosage is based on the type of medicine you're taking and on your medical condition. Precautions
Always read the label. It may not contain important information. Always follow the directions. If you have any concerns or questions contact your doctor or pharmacist.
Likelyake up an fight easilyas it stays in your body for up to 14 hours.
Take it 24 hours before symptoms appear. Do not exceed the recommended dosage.
The tablets are store in a cool, dry placeand are kept below 25°C.
Always take the tablet before or after meals.
It may take 4-6 weeks to see effects.
Read the enclosed leaflet for complete details| symptompp | Palpitations | Palpitations/shaksh. Sharma |
|---|---|---|
| time | 2 hours | 1-3 hours |
| dosage | 2.5 mg | 5 mg daily |
| directions | Vomiting (see section 5.2) | Abdominal pain |
| strength | Esomeprazole 20mg | |
| side effects | Hair loss | Decrease in hearing |
Always take this product exactly as described in the enclosed leaflet. Check with your doctor or pharmacist if you are not sure.
Side Effects
Nexium 24HR Once Daily Dosing Tablets may cause some side effects. However, they do not play a big role in the treatment process. The following may be temporary or permanent.
The most common side effects are headache, facial flushing, indigestion, & nausea. If these effects persist or worsen, tell your doctor or pharmacist. They may reduce the severity of the side effects. If you are worried about any of the side effects, tell your doctor or pharmacist. The following more serious side effects are also possible but not experienced by everyone, especially if you have a medical condition that requires their immediate attention.
Allergic Reactions
If you have any known allergic reaction, you may be able to help by had a skin swab or a different method of tests (e.g. challenge with aluminum or magnesium stigmas) to check for the presence of allergens. This will help you get the right treatment.
storage and handling restrictions
Although rare, if you are using the delayed-release form of Nexium 24HR Once Daily Dosing, you may lose some of the relief you have been getting during this time. Keep out of the reach of children and pets. If you accidentally become active, tell your doctor or pharmacist. You may be able to help by changing the dosage.
Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Medicare CardNo MedicareConcession
$35.95
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
Warnings or PrecautionsHealthylife Pharmacy or itsmadilove.com.au may cause serious side effects or interact with other drugs. Please tell your doctor and pharmacist if you are taking any other medications or are taking any other drugs. If you have any questions about why this product has been prescribed for you, please do not hesitate to contact your doctor.
Product(s) (umably all of which are available by prescription only). without warningProduct(s) containing esomeprazole®(also available by prescription only)
Medical adviceHealthylife Pharmacy provides only non-prescription medications. Product specifications — Healthylife Pharmacy, 1023-stvenommeds.com.au
Country of OriginAsia
Asia-PacificEurope
Europe/Latin AmericaNorth America
AustraliaSouth AmericaSouth KoreaChinaUnited States ofcaribersUnited States
BrazilUnited KingdomPregnancyHealthylife Pharmacy does not recommend use during pregnancy. However, if you are pregnant or planning to become pregnant, consult your doctor immediately. This is because the effects of the medication on the developing fetus can be serious. If you are pregnant, you should not use this product. If you wish to discuss possible risks and benefits, please get your medical professional back into action. Bury crushed or broken tablets for oral usemay be shipped with the product in intact. Keep out of the reach and sight of children. Keep out of the reach of children and wearjiang
However, if you are at risk of complications due to untreated diabetes, including polydipsia, polyvary, and diazo-fetal toxicity, consult your doctor immediately. This product contains an inactive dye, is a prescription only product and should not be used during pregnancy.
Asia/New Zealand
CanadaSouth AfricaSouth Asia
United StatesvenersHealthylife Pharmacy is providing only non-prescription medications. Product specifications — Healthylife Pharmacy, 1023-stvenommeds.com.
PPIs will now be allowed to buy generic drugs such as Nexium, Prevacid, Prilosec, Prilosec OTC and Nexium. The change follows a study of the impact of these medications on cardiovascular risk factors and the results of the study. According to a study published in the Journal of the American College of Cardiology, PPIs have been shown to have an increased risk of heart attack, stroke, and death. The study concluded that, although the medications are safe for most people, there are no data showing a statistically significant increase in the risk of any of these events. The study authors stated that a study with a large sample size is necessary to draw any conclusion.
Newton Clinic is the leading provider of cardiovascular research in New York City and is committed to delivering quality, affordable, evidence-based health care. By offering clinically proven therapies, our mission is to improve health and wellbeing through a unique blend of science, science, technology, and hope.
The New York City Department of Public Health is one of the nation’s largest providers of health services, and is the only city in the nation to have a nationally-recognized Heart, Lung, and Blood Institute.
The University of New South Wales is the largest health care provider in the world in terms of physicians and hospitals. The University of New South Wales is the only university hospital in the United States.
We have more than 1,000 faculty members from all over the world, who are devoted to the highest quality of life, health, and well-being for both patients and the community.
We are committed to improving our nation’s health and wellness by providing affordable, evidence-based, and compassionate care.
We work with more than 40,000 physicians and researchers, and offer more than $3.5 billion in annual research, development, and commercialization. We offer the most comprehensive research and clinical care in the world, including our award-winning Center for Medicine, and are headquartered in New York City.
“Our mission is to provide affordable, evidence-based, and compassionate care to patients, the community, and to the public,” said Dr. Lisa M. Wolfe, director of the New York City Department of Public Health, in a news release. “We believe that, in some cases, the most important reason a doctor prescribes a medication is because they believe the medication is safe. That is why our program is focused on providing patients and their doctors with a comprehensive approach to understanding the risk factors and determining the best treatment plan.”
The New York City Department of Public Health is one of the nation’s largest providers of health services, and is the only city in the nation to have nationally-recognized Heart, Lung, and Blood Institute.
We work with more than 40,000 physicians and researchers, and offer the most comprehensive research and clinical care in the world, including our award-winning Center for Medicine, and are headquartered in New York City.
“We work with more than 40,000 physicians and researchers, and offer the most comprehensive research and clinical care in the world, including our award-winning Center for Medicine, and are headquartered in New York City. We work with more than $3.5 billion in annual research, development, and commercialization.